Article
High-grade B-cell lymphoma not otherwise specified, with diffuse large B-cell lymphoma gene expression signatures: Genomic analysis and potential therapeutics.
American journal of hematology - 1 Jan 2025
Lone Waseem, Bouska Alyssa, Herek Tyler A, Amador Catalina, Song Joo, Xu Alexander M, Jochum Dylan, Issa Issa Ismail, Weisenburger Dennis D, Zhang Xuan, Bhagavathi Sharath Kumar, Heavican-Foral Tayla B, Sharma Sunandini, Shah Ab Rauf, Mir Abdul Rouf, Alkhinji Aisha Ahmad, El-Gamal Dalia, Dave Bhavana J, Hartert Keenan, Yu Jiayu, Saumyaranjan Mallick, Greiner Timothy C, Vose Julie, McKeithan Timothy W, Fu Kai, Green Michael, Bi Chengfeng, Merchant Akil, Chan Wing C, Iqbal Javeed
Abstract excerpt
High-grade B-cell lymphoma not otherwise specified (HGBCL, NOS) has overlapping morphological and genetic features with diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL), leading to uncertainty in its diagnosis and clinical management. Using functional genomic approaches, we previously characterized HGBCL and NOS, that demonstrate gene expression profiling (GEP), and genetic signatures similar to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
